AFP
Basic information
Region (hg38): 4:73431138-73456174
Previous symbols: [ "HPAFP" ]
Links
Phenotypes
GenCC
Source:
- congenital deficiency in alpha-fetoprotein (No Known Disease Relationship), mode of inheritance: AR
- hereditary persistence of alpha-fetoprotein (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
AFP deficiency, congenital; Hereditary persistence of AFP | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | General | 1690155; 1379776; 7684942; 15280901; 18854864 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AFP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 26 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 0 | 1 | 26 | 6 | 6 |
Variants in AFP
This is a list of pathogenic ClinVar variants found in the AFP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-73436100-G-A | Alpha-fetoprotein, hereditary persistence of | Affects (Jan 01, 2004) | ||
4-73436164-C-A | Alpha-fetoprotein, hereditary persistence of | Affects (Jan 01, 2004) | ||
4-73436294-T-C | not specified | Uncertain significance (Aug 01, 2024) | ||
4-73437192-G-A | not specified | Uncertain significance (May 02, 2024) | ||
4-73438182-T-C | not specified | Uncertain significance (Aug 12, 2024) | ||
4-73438185-T-A | AFP-related disorder | Likely benign (Feb 09, 2022) | ||
4-73438203-A-G | not specified | Uncertain significance (Mar 20, 2024) | ||
4-73440617-G-A | not specified | Uncertain significance (Jan 06, 2023) | ||
4-73440656-G-C | Benign (Aug 16, 2018) | |||
4-73440725-A-C | not specified | Uncertain significance (Dec 28, 2023) | ||
4-73440730-A-G | Likely benign (Apr 25, 2018) | |||
4-73440732-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
4-73440737-A-T | not specified | Uncertain significance (Aug 04, 2023) | ||
4-73440749-C-A | not specified | Uncertain significance (Dec 13, 2021) | ||
4-73440759-A-C | not specified | Uncertain significance (Feb 13, 2024) | ||
4-73442356-G-A | Alpha-fetoprotein deficiency | Pathogenic (Mar 01, 2009) | ||
4-73442363-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
4-73443426-C-T | not specified | Uncertain significance (Oct 08, 2024) | ||
4-73443443-A-C | not specified | Uncertain significance (Jun 26, 2023) | ||
4-73444988-C-T | Likely benign (Jul 17, 2018) | |||
4-73445078-G-A | not specified | Uncertain significance (Nov 13, 2024) | ||
4-73445102-C-G | not specified | Uncertain significance (Mar 21, 2023) | ||
4-73447452-T-C | AFP-related disorder | Benign (Oct 28, 2019) | ||
4-73447476-C-T | Benign (Dec 31, 2019) | |||
4-73447498-ACT-A | Alpha-fetoprotein deficiency | Pathogenic (Mar 01, 2009) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AFP | protein_coding | protein_coding | ENST00000395792 | 14 | 25037 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.14e-11 | 0.913 | 125675 | 0 | 73 | 125748 | 0.000290 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.185 | 302 | 311 | 0.970 | 0.0000148 | 4007 |
Missense in Polyphen | 70 | 97.289 | 0.71951 | 1326 | ||
Synonymous | 0.371 | 106 | 111 | 0.955 | 0.00000542 | 1096 |
Loss of Function | 1.99 | 23 | 35.8 | 0.642 | 0.00000178 | 448 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000423 | 0.000420 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00147 | 0.00147 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000239 | 0.000237 |
Middle Eastern | 0.00147 | 0.00147 |
South Asian | 0.000196 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds copper, nickel, and fatty acids as well as, and bilirubin less well than, serum albumin. Only a small percentage (less than 2%) of the human AFP shows estrogen-binding properties.;
- Disease
- DISEASE: Alpha-fetoprotein deficiency (AFPD) [MIM:615969]: A benign condition characterized by undetectable AFP levels in the amniotic fluid. Affected individuals are asymptomatic and present normal development. {ECO:0000269|PubMed:15280901, ECO:0000269|PubMed:18854864}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Alpha-fetoprotein, hereditary persistence (HPAFP) [MIM:615970]: A benign autosomal dominant condition characterized by continued expression of alpha-fetoprotein in adult life. {ECO:0000269|PubMed:7684942}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Hippo signaling pathway - Homo sapiens (human);Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;p73 transcription factor network;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Glucocorticoid receptor regulatory network;Direct p53 effectors;FOXA2 and FOXA3 transcription factor networks
(Consensus)
Recessive Scores
- pRec
- 0.750
Intolerance Scores
- loftool
- 0.859
- rvis_EVS
- 0.29
- rvis_percentile_EVS
- 71.57
Haploinsufficiency Scores
- pHI
- 0.580
- hipred
- N
- hipred_score
- 0.469
- ghis
- 0.512
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.928
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Afp
- Phenotype
- homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; reproductive system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); neoplasm;
Gene ontology
- Biological process
- ovulation from ovarian follicle;progesterone metabolic process;post-translational protein modification;cellular protein metabolic process;SMAD protein signal transduction
- Cellular component
- extracellular space;endoplasmic reticulum lumen
- Molecular function
- protein binding;metal ion binding